Buy CL Stock At $80?
Colgate-Palmolive stock (NYSE: CL) has decreased by 12% this year, lagging behind the S&P 500, which has risen by 13%. This drop is primarily attributed to various factors, such as slowing sales growth, with the company projecting only about 2% organic sales growth for 2025.
Colgate-Palmolive: A Defensive Staple With Meaningful Upside
Colgate-Palmolive remains a global leader in oral care, boasting strong brand equity, innovation, and a 62-year dividend growth streak. CL demonstrates resilience amid inflation, with robust margins, an improving debt profile, and potential for further growth in emerging markets and sustainable products. DCF analysis and analyst consensus suggest CL is fairly valued but offers 15% upside, supported by a 'Buy' rating from most analysts.
Here's Why Colgate-Palmolive (CL) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Can Colgate's New Productivity Program Drive Long-Term Growth?
Colgate launches a $300-$400M productivity program to boost efficiency, cut costs and fuel long-term growth amid market pressures.
Colgate-Palmolive Company (CL) Presents At Barclays 18th Annual Global Consumer Staples Conference 2025 Transcript
Colgate-Palmolive Company (NYSE:CL ) Barclays 18th Annual Global Consumer Staples Conference 2025 September 3, 2025 9:00 AM EDT Company Participants Noel Wallace - Chairman, CEO & President Conference Call Participants Lauren Lieberman - Barclays Bank PLC, Research Division Presentation Lauren Lieberman MD & Senior Research Analyst Okay. We're going to get started.
Why Colgate-Palmolive (CL) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Will Colgate's Innovation Drive Market Share Gains in 2025?
CL's innovation push spans premium oral, personal, home and pet care to drive market share growth in 2025 despite headwinds.
3 Bargain-Basement Dividend Stocks to Buy Now Before Their Discounts Disappear
Key Points in This Article: Consumer staple stocks provide stability due to consistent demand for essential goods, making them reliable investments in any market.
Colgate-Palmolive Company (CL) Q2 2025 Earnings Call Transcript
Colgate-Palmolive Company (NYSE:CL ) Q2 2025 Earnings Conference Call August 1, 2025 8:30 AM ET Company Participants John Faucher - Chief Investor Relations Officer and Executive VP of M&A Noel R. Wallace - Chairman, CEO & President Stanley J.
Colgate Tops Q2 Earnings & Sales Estimates, Tweaks Organic Sales View
CL beats Q2 earnings and sales estimates on pricing and organic growth but narrows the full-year organic sales view to the low end of the 2-4% range.
Nonfarm Payrolls Come in SIgnificantly Below Expectations
Nonfarm Payrolls Come in SIgnificantly Below Expectations.
Compared to Estimates, Colgate-Palmolive (CL) Q2 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Colgate-Palmolive (CL) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
